Ticker

Analyst Price Targets — PED

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
December 22, 2022 7:05 amEF Hutton$48.00$23.40Benzinga EF Hutton Assumes PEDEVCO at Buy, Announces Price Target of $2.4

Latest News for PED

Enhanced Group: A Bet On Peptide And PED Overton Window Shift

Enhanced Group Inc. is a highly differentiated and ambitious telehealth company. The company offers peptides and supplemental health products to enhance performance. ENHA is trying to capture interest from a growing biohacking market, but the market's controversy and peptides' unreliable health results may weaken market potential. The Enhanced Games, a massive marketing funnel for ENHA, had a mixed inaugural event.…

Seeking Alpha • May 27, 2026
Pedevco: Juniper Capital Advisors Makes A Material Investment

PEDEVCO undergoes a transformative investment and asset acquisition by Juniper Capital Advisors. PED's production has surged from 1,000 BOED to over 6,000 BOED. This materially improves financial prospects. The company received a critical cash injection. That changes the future from a cash-starved past to a growth-oriented strategy focused on bolt-on acquisitions and operational efficiency.

Seeking Alpha • May 17, 2026
Pedevco Q1 Earnings Call Highlights

Pedevco NYSEAMERICAN: PED reported first-quarter 2026 results that management said exceeded internal expectations in the company's first full quarter following its merger with Juniper, with higher production from DJ Basin wells driving a sharp year-over-year increase in revenue and Adjusted EBITDA.

MarketBeat • May 15, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for PED.

No House trades found for PED.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top